Here, we demonstrated that the MDM4 inhibitor CEP-1347 markedly increased MDM2 expression in malignant brain tumor cells, which, in turn, interfered with the CEP-1347-induced activation of p53, which may be effectively prevented by blocking the MDM2–p53 interaction. The gene discussed is TP53; the disease is brain neoplasm.